Evaluation of Liver Stiffness by Ultrasound Elastography for Predicting Early HCC Recurrence After Treatment
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HepATocellular Cancer Hcv Therapy Study
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE2
TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 Trial
- Status
- UNKNOWN
- Phase
- NA
Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Liver Disease and Other Systemic Diseases
- Status
- RECRUITING
- Phase
- N/A
Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells
- Status
- UNKNOWN
- Phase
- NA
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer
- Status
- TERMINATED
- Phase
- NA
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis
- Status
- RECRUITING
- Phase
- N/A
Effects of Anesthetic Methods on Hepatic Cancer Cell Function in Vitro
- Status
- COMPLETED
- Phase
- NA
A Multicenter Cancer Biospecimen Collection Study
- Status
- RECRUITING
- Phase
- N/A
GPC3-CAR-T Cells for the Hepatocellular Carcinoma
- Status
- SUSPENDED
- Phase
- PHASE1